REIT - Healthcare Facilities · NYSE
Current Price
$17.10
PE Ratio (TTM)
32.9x
Intrinsic Value
Outside reliable range
COMPETITIVE MOAT
↑Prime Healthcare Real Estate Locations
Healthpeak owns strategically located, high-quality medical office buildings and life science facilities. These prime locations are difficult for competitors to replicate.
↑Long-Term Tenant Relationships
The company cultivates strong, long-term relationships with healthcare providers. This leads to high occupancy rates and predictable rental income streams.
↑Specialized Asset Class Expertise
Healthpeak possesses deep knowledge and experience in managing complex healthcare real estate. This specialization creates barriers to entry for generalist real estate investors.
INVESTMENT RISKS
↓Healthcare Industry Regulatory Changes
Changes in healthcare policy, reimbursement rates, or healthcare delivery models could negatively affect tenant demand and profitability.
↓Life Science Sector Volatility
The life science real estate market can be cyclical and influenced by R&D funding and drug development success. This creates potential for demand fluctuations.
↓Competition for Acquisitions
The attractive nature of healthcare real estate can lead to intense competition for new acquisitions, potentially driving up purchase prices and reducing returns.
Base case
Base case assumptions: -19.4% annual earnings growth, 19.21x target PE, 10% discount rate, 5 year projection. Data as of 2024-03-01.
This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Healthpeak Properties, Inc. respond.
Open PE Calculator for PEAKHealthpeak Properties, Inc., an S&P 500 constituent, operates as a fully integrated real estate investment trust (REIT). The company specializes in the acquisition and development of premium properties across three private-pay healthcare segments: Life Science, Medical Office, and Senior Housing. This focus is meticulously crafted to deliver stability amidst the cyclical nature of the industry. Healthpeak leverages its profound expertise in the healthcare property market, coupled with an ambitious outlook for sustained, long-term expansion.
PE Ratio (TTM)
32.9x
PEG Ratio
0.01
Earnings Yield
5.22%
ROE (TTM)
8.0%
Revenue/Share (TTM)
$4.42
Dividend Yield
7.02%
The trailing twelve-month PE ratio of PEAK reflects how much investors pay per dollar of Healthpeak Properties, Inc.'s earnings. This metric is most useful when compared to REIT - Healthcare Facilities peers and the company's own historical range.
PEAK's PE of 32.9x combined with a PEG ratio of 0.01 provides a growth-adjusted perspective. A PEG below 1.0 means the P/E is low relative to the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical REIT - Healthcare Facilities, a DCF analysis may be more appropriate.
To value Healthpeak Properties, Inc. using PE: (1) Compare the current PE (32.9x) against the REIT - Healthcare Facilities median to assess relative pricing, (2) check the PEG ratio (0.01) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
PEAK's PEG ratio is 0.01, calculated by dividing the PE ratio (32.9x) by the expected earnings growth rate. A PEG below 1.0 means the P/E is low relative to the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how PEAK is priced versus REIT - Healthcare Facilities peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value PEAK with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2024-03-01. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.